Analyst Upgrades: Texas Instruments Inc., Potash Corporation of Saskatchewan Inc., and UnitedHealth Group Incorporated

Analysts upwardly revised their ratings on Texas Instruments Incorporated (TXN), Potash Corp./Saskatchewan (USA) (POT), UnitedHealth Group Inc. (UNH)

by Josh Selway

Published on Jan 27, 2015 at 9:21 AM
Updated on Apr 20, 2015 at 5:32 PM

Analysts are weighing in today on semiconductor manufacturer Texas Instruments Incorporated (NASDAQ:TXN), fertilizer concern Potash Corp./Saskatchewan (USA) (NYSE:POT), and blue chip UnitedHealth Group Inc. (NYSE:UNH). Here's a quick roundup of today's bullish brokerage notes on TXN, POT, and UNH.

  • TXN is off 0.9% in electronic trading, despite seeing its price target raised by no fewer than seven brokerage firms after posting higher fourth-quarter results. The most ambitious of the bunch was RBC, which raised its price target to $66 from $65, and kept its "outperform" rating. Elsewhere, Texas Instruments Incorporated has been stellar on the charts, adding 32.8% from its October low of $41.47 to close yesterday at $55.05. Still, analysts have been slow to give TXN the credit it deserves, as 65% of brokerage firms maintain "hold" or worse ratings. Plus, the stock has already surpassed its consensus 12-month price target of $53.18. Should the security's strong technical run continue, additional price-target increases and/or upgrades could add even more fuel to its fire.

  • POT had its price-target lifted by three brokerage firms. Specifically, TD Securities and HSBC both raised their target prices to $41 -- from $40 and $35.25, respectively -- while deeming the stock a "buy." Also, Susquehanna raised its target price by $3 to $35, while keeping its "neutral" rating. The positive attention is nothing new for a stock that has added over 12% in the past year to finish yesterday at $35.89. Option traders have kept their bearish stance, though, picking up puts ahead of Thursday morning's earnings report. Potash Corp./Saskatchewan's (POT) 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.62 ranks in the 68th annual percentile, suggesting speculators have bought to open puts over calls at an accelerated clip in the past two weeks.

  • Finally, even with a price-target hike from Oppenheimer to $128 -- territory never before explored -- from $115, UNH is down 0.5% in pre-market trading, pressured by its fellow blue chips. Regardless, the stock has been a technical standout, outperforming the S&P 500 Index (SPX) by roughly 16 percentage points in the past three months, closing yesterday at $111.61. In fact, the equity tagged a record high of $114.32 on Friday. In UnitedHealth Group Inc.'s options pits, however, short-term speculators have taken a put-skewed approach. The stock's Schaeffer's put/call open interest ratio (SOIR) of 1.02 outranks 70% of all readings in the past year.

A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

Legendary Stock-Picker Calls Top Stock of 2020
Matt McCall's picks were met with disbelief... Until five soared over 1,000%. Get his latest 2020 pick.
Patent Lawsuit Loss Sends AMRN Stock Spiraling
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa
RH Stock Sinks Despite Earnings Beat
J.P. Morgan Securities and Cowen and Company cut their price targets
The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.